Alive announced the initial closing of ALIVE Growth Fund III, a $180–200M growth-stage HealthTech fund investing in Israeli and international mid-to-late stage Medical Device and Digital Health companies.
Navina was ranked among the Top 5 Best Startups to Work For by Dun’s 100, recognizing its organizational culture and growth trajectory.
Axonius acquired Cynerio, an ALIVE portfolio company focused on healthcare cybersecurity, in a transaction valued at over $100M. The acquisition expands Axonius’ capabilities in securing connected medical devices and healthcare infrastructure.
Edwards Lifesciences announced the acquisition of Innovalve, an Alive portfolio company developing a transcatheter mitral valve replacement solution. The transaction was reported at a valuation of approximately $350M.
OncoHost received the Gold Award at the 2025 Merit Awards for Business in the Research and Development category. The recognition highlights the company’s scientific and clinical innovation in precision oncology.
OncoHost was named “Proteomics Innovation of the Year” at the 2025 BioTech Breakthrough Awards for its AI-driven proteomics platform supporting precision oncology decision-making.
Navina closed a $55M Series C funding round led by Goldman Sachs Alternatives, bringing its total funding to $100M. The round supports continued expansion of Navina’s AI-powered clinical intelligence platform in the U.S. market.
Wisdo Health completed a $5M extension to its Series A round, bringing total Series A funding to $11M and supporting expansion of its peer-support mental health platform.
Magenta Medical announced the closing of a $105M financing round to advance its clinical programs and support progress toward U.S. regulatory approval.
Alive reported its first exit as Innovalve was acquired by Edwards Lifesciences in a transaction valued at over $300M. The deal underscores ALIVE’s focus on clinically driven innovation with clear strategic exit pathways.
Magenta Medical raised $55M in funding led by OrbiMed to support late-stage clinical development of its heart pump technology.
OncoHost raised $35M in a Series C round led by ALIVE to expand clinical trials and prepare for U.S. commercialization of its proteomics platform.
Cynerio raised $30M in a Series B round led by ALIVE to scale its healthcare cybersecurity platform and expand hospital deployments globally.
Medisafe secured $30M in Series C funding to expand its digital medication management platform and partnerships with global pharma companies.
Alive announced significant capital commitments from strategic healthcare and financial partners as it launched its initial investment activity. The funding supported Alive’s early portfolio construction in medical devices and digital health.
Alive was introduced as a new HealthTech investment fund targeting Israeli medical device and digital health companies, with a focus on late pre-clinical and clinical-stage assets.
